---
title: "Ophthalmology concept experiences a volatile rebound, TMSP hits the limit up"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/250057469.md"
description: "The ophthalmology concept experienced a volatile rebound, with TMSP hitting the limit up, followed by gains in Xingqi Pharmaceutical, Laimei Pharmaceutical, Nosseland, Daheng Technology, Guanhao Biological, and Doctor Glasses"
datetime: "2025-07-25T01:58:33.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/250057469.md)
  - [en](https://longbridge.com/en/news/250057469.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/250057469.md)
---

# Ophthalmology concept experiences a volatile rebound, TMSP hits the limit up

The ophthalmology concept experienced a volatile rebound, with TMSP hitting the limit up, followed by gains in Xingqi Pharmaceutical, Laimei Pharmaceutical, Nostrand, Daheng Technology, Guanhao Biological, and Doctor Glasses

### Related Stocks

- [300573.CN](https://longbridge.com/en/quote/300573.CN.md)
- [600671.CN](https://longbridge.com/en/quote/600671.CN.md)

## Related News & Research

- [Advance Metals Moves Towards Full Ownership of Myrtleford and Beaufort Gold Projects](https://longbridge.com/en/news/287147459.md)
- [14:47 ET6th Annual Midwest Design Awards Entry Period Now Open](https://longbridge.com/en/news/286808240.md)
- [BRIEF-Mexico's Fibra Next Extends, Raises Public Offer For Fibra Macquarie](https://longbridge.com/en/news/287128862.md)
- [Alibaba unveils new Qwen model, custom chips in bid to become China’s AI factory](https://longbridge.com/en/news/287044112.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)